HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Diagnosis of granulocytic sarcoma facilitated by monoclonal antibodies.

Abstract
A 36 year old woman presented with a nasopharyngeal tumour which was diagnosed and treated as diffuse large cell lymphoma. Twelve mth later the patient developed acute myeloid leukemia. At this stage, the original biopsies were reviewed and considered in retrospect to be granulocytic sarcoma on the basis of staining for chloracetate esterase and lysozyme. She achieved and maintained marrow and peripheral blood remission with chemotherapy, but developed several cutaneous nodules and 2 breast lumps. One breast lump was excised and was found, by the use of monoclonal antibodies, to carry myeloid markers. Thus monoclonal antibodies provided additional confirmatory evidence for the diagnosis of granulocytic sarcoma.
AuthorsS K Juneja, G R Pilkington, J C Ding, I A Cooper
JournalPathology (Pathology) Vol. 18 Issue 4 Pg. 469-72 (Oct 1986) ISSN: 0031-3025 [Print] England
PMID3469612 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • Carboxylic Ester Hydrolases
  • chloroacetate esterase
  • Muramidase
Topics
  • Adult
  • Antibodies, Monoclonal
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Carboxylic Ester Hydrolases (metabolism)
  • Female
  • Humans
  • Leukemia, Myeloid (diagnosis, drug therapy, enzymology)
  • Muramidase (metabolism)
  • Nasopharyngeal Neoplasms (diagnosis, drug therapy, enzymology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: